CORRELATION BETWEEN COVID-19 SEVERITY AND NONINVASIVE ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)

被引：0
|
作者：
Tungtrongchitr, Nuttapat
Srivanitchapoom, Nantaporn
Hirunpat, Pornrujee
Sungkanuparph, Somnuek
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
MAFLD; COVID-19; fibrosis; 8; score; 4; non-alcoholic fatty liver disease fibrosis score;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1509
引用
收藏
页码：S1394 / S1395
页数：2
相关论文
共 50 条
  • [1] Correlation Between Coronavirus Disease 2019 Severity and Noninvasive Assessment of Liver Fibrosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
    Tungtrongchitr, Nuttapat
    Srivanitchapoom, Nantaporn
    Hirunpat, Pornrujee
    Sungkanuparph, Somnuek
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (12`): : 1227 - 1234
  • [2] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    LIVERS, 2023, 3 (04): : 597 - 617
  • [3] Updates in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Children
    Rupasinghe, Kushila
    Hind, Jonathan
    Hegarty, Robert
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (05): : 583 - 591
  • [4] Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19
    Brilakis, Leonidas
    Theofilogiannakou, Eirini
    Lykoudis, Panagis M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (11) : 1480 - 1487
  • [5] Risk of the Development of Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Rheumatoid Arthritis
    Aydin, Murat
    Aksakal, Berrin
    Basat, Sema
    ISTANBUL MEDICAL JOURNAL, 2023, 24 (04): : 357 - 363
  • [6] Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
    Barchetta, Ilaria
    Cimini, Flavia Agata
    Cavallo, Maria Gisella
    NUTRIENTS, 2020, 12 (11) : 1 - 14
  • [7] Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19
    Targher, G.
    Mantovani, A.
    Byrne, C. D.
    Wang, X. -B.
    Yan, H. -D.
    Sun, Q. -F.
    Pan, K. -H.
    Zheng, K. I.
    Chen, Y. -P.
    Eslam, M.
    George, J.
    Zheng, M. -H.
    DIABETES & METABOLISM, 2020, 46 (06) : 505 - 507
  • [8] Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis
    Tincopa, Monica A.
    Loomba, Rohit
    SEMINARS IN LIVER DISEASE, 2024, 44 (03) : 287 - 299
  • [9] Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
    Huang, Jee-Fu
    Tsai, Pei-Chien
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Huang, Ching-, I
    Lee, Mei-Hsuan
    Hsu, Po-Yau
    Wang, Chih-Wen
    Wei, Yu-Ju
    Liang, Po-Cheng
    Lin, Yi-Hung
    Hsieh, Meng-Hsuan
    Yang, Jeng-Fu
    Hsieh, Ming-Yen
    Jang, Tyng-Yuan
    Bair, Ming-Jong
    Lin, Zu-Yau
    Dai, Chia-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (05) : 1061 - 1068
  • [10] Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Prasoppokakorn, Thaninee
    Pitisuttithum, Panyavee
    Treeprasertsuk, Sombat
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (06) : 939 - 946
12345